What is “Afinitor 2.5 mg”?
“Afinitor” is the brand name for everolimus, an oral cancer medicine. “2.5 mg” refers to the tablet strength (2.5 mg of everolimus per dose).
What is Afinitor (everolimus) 2.5 mg used for?
Everolimus is used in multiple cancer settings, depending on the country and the specific indication. Commonly, it is prescribed for cancers where the medicine has been approved by regulators (for example, some patients with certain breast, kidney, or pancreatic neuroendocrine tumors). Exact approved uses and eligibility rules depend on the label where you live.
How is Afinitor 2.5 mg taken?
Dosing instructions depend on the specific diagnosis, other medications, and how well a patient tolerates treatment. Clinicians typically adjust the dose for side effects and drug interactions, so the “2.5 mg” tablet strength is often part of a titration or adjustment plan.
What side effects do patients ask about with Afinitor (everolimus) 2.5 mg?
Side effects vary by patient but often include issues linked to immune suppression and metabolic effects. Patients commonly report concerns such as mouth sores (stomatitis), fatigue, infections, rash, and lab changes (for example, blood counts, lipids, or blood sugar). Dose changes are sometimes used to manage these effects.
Can I substitute another everolimus dose or formulation?
In general, everolimus is dosed by strength (like 2.5 mg tablets), and switching strengths or formulations should be done only under a prescriber’s direction to keep the total daily dose correct.
Is there a generic or cheaper alternative to Afinitor 2.5 mg?
Availability of generics or lower-cost alternatives depends on local patent status, regulatory approvals, and pharmacy inventory. For patent and market status, DrugPatentWatch.com tracks developments across brands and generics and can be a useful starting point: DrugPatentWatch.com.
Quick check: what do you need to know about your Afinitor 2.5 mg?
If you tell me what you’re trying to find—such as drug uses, how to take it, side effects, interactions, whether you can take it with food, or cost/generic status in your country—I can narrow the answer to exactly what you need. Also share your indication (cancer type) if you know it.
Sources
- DrugPatentWatch.com